CRNX
Price
$45.91
Change
+$10.02 (+27.92%)
Updated
Sep 26 closing price
Capitalization
4.32B
40 days until earnings call
RZLT
Price
$9.34
Change
+$0.57 (+6.50%)
Updated
Sep 26 closing price
Capitalization
848.18M
40 days until earnings call
Interact to see
Advertisement

CRNX vs RZLT

Header iconCRNX vs RZLT Comparison
Open Charts CRNX vs RZLTBanner chart's image
Crinetics Pharmaceuticals
Price$45.91
Change+$10.02 (+27.92%)
Volume$10.22M
Capitalization4.32B
Rezolute
Price$9.34
Change+$0.57 (+6.50%)
Volume$1.96M
Capitalization848.18M
CRNX vs RZLT Comparison Chart in %
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. RZLT commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a Buy and RZLT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (CRNX: $45.91 vs. RZLT: $9.34)
Brand notoriety: CRNX and RZLT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 774% vs. RZLT: 180%
Market capitalization -- CRNX: $4.32B vs. RZLT: $848.18M
CRNX [@Biotechnology] is valued at $4.32B. RZLT’s [@Biotechnology] market capitalization is $848.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileRZLT’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • RZLT’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRNX and RZLT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 6 TA indicator(s) are bullish while RZLT’s TA Score has 4 bullish TA indicator(s).

  • CRNX’s TA Score: 6 bullish, 4 bearish.
  • RZLT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than RZLT.

Price Growth

CRNX (@Biotechnology) experienced а +35.39% price change this week, while RZLT (@Biotechnology) price change was +21.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

CRNX is expected to report earnings on Nov 06, 2025.

RZLT is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($4.32B) has a higher market cap than RZLT($848M). RZLT YTD gains are higher at: 90.612 vs. CRNX (-10.209). RZLT has higher annual earnings (EBITDA): -77.12M vs. CRNX (-419.62M). CRNX has more cash in the bank: 1.2B vs. RZLT (86.9M). RZLT has less debt than CRNX: RZLT (1.78M) vs CRNX (49.9M). CRNX has higher revenues than RZLT: CRNX (1.39M) vs RZLT (0).
CRNXRZLTCRNX / RZLT
Capitalization4.32B848M510%
EBITDA-419.62M-77.12M544%
Gain YTD-10.20990.612-11%
P/E RatioN/AN/A-
Revenue1.39M0-
Total Cash1.2B86.9M1,376%
Total Debt49.9M1.78M2,811%
FUNDAMENTALS RATINGS
CRNX vs RZLT: Fundamental Ratings
CRNX
RZLT
OUTLOOK RATING
1..100
2080
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
39
Fair valued
PROFIT vs RISK RATING
1..100
50100
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
4835
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5039

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RZLT's Valuation (39) in the null industry is somewhat better than the same rating for CRNX (89) in the Pharmaceuticals Major industry. This means that RZLT’s stock grew somewhat faster than CRNX’s over the last 12 months.

CRNX's Profit vs Risk Rating (50) in the Pharmaceuticals Major industry is somewhat better than the same rating for RZLT (100) in the null industry. This means that CRNX’s stock grew somewhat faster than RZLT’s over the last 12 months.

CRNX's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as RZLT (99) in the null industry. This means that CRNX’s stock grew similarly to RZLT’s over the last 12 months.

RZLT's Price Growth Rating (35) in the null industry is in the same range as CRNX (48) in the Pharmaceuticals Major industry. This means that RZLT’s stock grew similarly to CRNX’s over the last 12 months.

RZLT's P/E Growth Rating (100) in the null industry is in the same range as CRNX (100) in the Pharmaceuticals Major industry. This means that RZLT’s stock grew similarly to CRNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRNXRZLT
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 4 days ago
88%
Declines
ODDS (%)
Bearish Trend 6 days ago
77%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RINCX20.200.26
+1.30%
Victory RS Science and Technology C
SFMRX43.580.44
+1.02%
American Beacon Stephens Mid-Cap Gr R6
MTRCX20.380.13
+0.64%
MFS Total Return C
ACFCX74.580.40
+0.54%
American Century Focused Dynamic Gr R
JAVAX15.960.04
+0.25%
James Aggressive Allocation

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+27.92%
XNCR - CRNX
62%
Loosely correlated
+12.00%
NUVL - CRNX
57%
Loosely correlated
+4.99%
IDYA - CRNX
56%
Loosely correlated
+4.44%
DYN - CRNX
56%
Loosely correlated
+4.53%
VRDN - CRNX
55%
Loosely correlated
+5.82%
More

RZLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RZLT has been loosely correlated with SYRE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RZLT jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RZLT
1D Price
Change %
RZLT100%
+6.50%
SYRE - RZLT
44%
Loosely correlated
+4.04%
DYN - RZLT
43%
Loosely correlated
+4.53%
TERN - RZLT
43%
Loosely correlated
+2.69%
CRNX - RZLT
43%
Loosely correlated
+27.92%
AVBP - RZLT
42%
Loosely correlated
+5.01%
More